Queensgrove Ltd Filleted accounts for Companies House (small and micro)

Queensgrove Ltd Filleted accounts for Companies House (small and micro)

QUEENSGROVE LIMITED - Company Information

Print Friendly Version

0 false false false false false false true false false true false false false false false false No description of principal activity 2019-07-01 Sage Accounts Production Advanced 2020 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 08123852 2019-07-01 2020-06-30 08123852 2020-06-30 08123852 2019-06-30 08123852 bus:Director1 2019-07-01 2020-06-30 08123852 core:WithinOneYear 2020-06-30 08123852 core:WithinOneYear 2019-06-30 08123852 core:ShareCapital 2020-06-30 08123852 core:ShareCapital 2019-06-30 08123852 core:CostValuation core:Non-currentFinancialInstruments 2020-06-30 08123852 core:Non-currentFinancialInstruments 2020-06-30 08123852 core:Non-currentFinancialInstruments 2019-06-30 08123852 bus:SmallEntities 2019-07-01 2020-06-30 08123852 bus:AuditExempt-NoAccountantsReport 2019-07-01 2020-06-30 08123852 bus:FullAccounts 2019-07-01 2020-06-30 08123852 bus:SmallCompaniesRegimeForAccounts 2019-07-01 2020-06-30 08123852 bus:PrivateLimitedCompanyLtd 2019-07-01 2020-06-30
COMPANY REGISTRATION NUMBER: 08123852
Queensgrove Ltd
Filleted Unaudited Financial Statements
30 June 2020
Queensgrove Ltd
Statement of Financial Position
30 June 2020
2020
2019
Note
£
£
£
Fixed assets
Investments
4
51
51
Current assets
Cash at bank and in hand
100
100
Creditors: amounts falling due within one year
5
51
51
----
----
Net current assets
49
49
----
----
Total assets less current liabilities
100
100
----
----
Capital and reserves
Called up share capital
100
100
----
----
Shareholders funds
100
100
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
The company did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 30 June 2020 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 28 May 2021 , and are signed on behalf of the board by:
A.B. Ioannou
Director
Company registration number: 08123852
Queensgrove Ltd
Notes to the Financial Statements
Year ended 30 June 2020
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 34-35 Eastcastle St, W1W 8DW.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders funds during the current year or prior year.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Investments
Shares in group undertakings
Shares in participating interests
Total
£
£
£
Cost
At 1 July 2019 and 30 June 2020
50
1
51
----
----
----
Impairment
At 1 July 2019 and 30 June 2020
–
–
–
----
----
----
Carrying amount
At 30 June 2020
50
1
51
----
----
----
At 30 June 2019
50
1
51
----
----
----
The company’s investments at the balance sheet date and key financial information at 31 August 2020 (the nearest available accounts) are:
2020
2019
£
Subsidiary
Abacus Ark Limited (50% ordinary shares)
Aggregate capital & reserves
(1,806,147)
(1,453,947)
Loss for the year
352,200
360,513
Associate
Abacus Ark 2 Limited (33% ordinary shares)
Aggregate capital & reserves
(3,177,133)
(3,095,625)
Loss for the year
81,508
138,926
5. Creditors: amounts falling due within one year
2020
2019
£
£
Other creditors
51
51
----
----